Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longlong Luo

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Dermatological Science|March 28, 2026
Single-cell RNA sequencing identifies long non-coding RNAs enriched in psoriatic epidermal subsetsLonglong Luo, Jan Cedric Freisenhausen, Devin Malitha Dompage, et al.
Bioorganic Chemistry|September 24, 2021
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulationDian Xiao, Longlong Luo, Jiaguo Li, et al.
Frontiers in Immunology|December 15, 2022
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacyNing Shi, Yangyihua Zhou, Yujun Liu, et al.
International Journal of Molecular Sciences|June 13, 2025
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain AntibodiesKexuan Cheng, Jiazheng Guo, Yating Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2023
High-affinity decoy protein, nFD164, with an inactive Fc region as a potential therapeutic drug targeting CD47Zhihong Wang, Naijing Hu, Haitao Wang, et al.
Materials Today. Bio|May 25, 2026
Tailoring virus-inspired nanoparticles for advanced drug and gene deliveryRuilin Zhou, Miao Xu, Xuting Zheng, et al.
Immunologic Research|February 11, 2022
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseasesNing Shi, Zhihong Wang, Hecheng Zhu, et al.
Journal of Medicinal Chemistry|November 13, 2020
Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In VivoJialin Guo, Longlong Luo, Zhihong Wang, et al.
Scandinavian Journal of Immunology|May 11, 2019
A novel human anti-AXL monoclonal antibody attenuates tumour cell migrationYanting Duan, Longlong Luo, Chunxia Qiao, et al.
Biotechnology Letters|June 1, 2017
Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancerChunxia Qiao, Xiaoling Lang, Longlong Luo, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Dermatological Science|March 28, 2026
Single-cell RNA sequencing identifies long non-coding RNAs enriched in psoriatic epidermal subsetsLonglong Luo, Jan Cedric Freisenhausen, Devin Malitha Dompage, et al.
Bioorganic Chemistry|September 24, 2021
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulationDian Xiao, Longlong Luo, Jiaguo Li, et al.
Frontiers in Immunology|December 15, 2022
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacyNing Shi, Yangyihua Zhou, Yujun Liu, et al.
International Journal of Molecular Sciences|June 13, 2025
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain AntibodiesKexuan Cheng, Jiazheng Guo, Yating Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2023
High-affinity decoy protein, nFD164, with an inactive Fc region as a potential therapeutic drug targeting CD47Zhihong Wang, Naijing Hu, Haitao Wang, et al.
Materials Today. Bio|May 25, 2026
Tailoring virus-inspired nanoparticles for advanced drug and gene deliveryRuilin Zhou, Miao Xu, Xuting Zheng, et al.
Immunologic Research|February 11, 2022
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseasesNing Shi, Zhihong Wang, Hecheng Zhu, et al.
Journal of Medicinal Chemistry|November 13, 2020
Design, Synthesis, and Biological Evaluation of Linear Aliphatic Amine-Linked Triaryl Derivatives as Potent Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction with Promising Antitumor Effects In VivoJialin Guo, Longlong Luo, Zhihong Wang, et al.
Scandinavian Journal of Immunology|May 11, 2019
A novel human anti-AXL monoclonal antibody attenuates tumour cell migrationYanting Duan, Longlong Luo, Chunxia Qiao, et al.
Biotechnology Letters|June 1, 2017
Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancerChunxia Qiao, Xiaoling Lang, Longlong Luo, et al.
Pageof 7